Shanghai Chematis Co., Ltd.

Established in 2004, Shanghai Chematis Co., Ltd. (chematis.com.cn) works as an agent and trading company offering a very wide portfolio of active pharmaceutical ingredients spanning cardiovascular drugs (losartan potassium, telmisartan, irbesartan, simvastatin, atorvastatin calcium, rosuvastatin calcium, captopril, enalapril maleate), oncology APIs (paclitaxel, oxaliplatin, cisplatin, carboplatin, docetaxel, vincristine and vinblastine sulfate), antibiotics (ceftriaxone sodium, vancomycin HCl, azithromycin dihydrate, clarithromycin), hormones and steroids (levonorgestrel, mifepristone, dutasteride, fluticasone propionate), and peptides such as octreotide, calcitonin and bivalirudin, alongside numerous chiral intermediates used in their synthesis. Its product categories include prophylactic biological products, cardiovascular system drugs, chiral intermediates, anti-tumor preparations and other antibiotics, and it offers OEM support. The company positions itself on internationally recognized approvals and standards, favorable delivery terms, a large product line, willingness to meet buyers' specifications, and its reputation for quality service, selling into Central and South America, Eastern and Western Europe, Asia, the Middle East, North America, Australasia and Africa.